Amygdalin alleviates renal injury by suppressing inflammation, oxidative stress and fibrosis in streptozotocin-induced diabetic rats
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Amygdalin alleviates renal injury by suppressing inflammation, oxidative stress and fibrosis in streptozotocin-induced diabetic rats
Authors
Keywords
Amygdalin, Diabetic nephropathy, TGF-β1/Smad pathway, Oxidative stress, Fibrosis
Journal
LIFE SCIENCES
Volume 265, Issue -, Pages 118835
Publisher
Elsevier BV
Online
2020-11-28
DOI
10.1016/j.lfs.2020.118835
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phytochemical profiling, antioxidant and HepG2 cancer cells’ antiproliferation potential in the kernels of apricot cultivars
- (2019) Yongsheng Chen et al. SAUDI JOURNAL OF BIOLOGICAL SCIENCES
- Soluble klotho as a marker of renal fibrosis and podocyte injuries in human kidneys
- (2018) Nam-Jun Cho et al. PLoS One
- Amygdalin attenuates acute liver injury induced by D-galactosamine and lipopolysaccharide by regulating the NLRP3, NF-κB and Nrf2/NQO1 signalling pathways
- (2018) Fayin Tang et al. BIOMEDICINE & PHARMACOTHERAPY
- Protective Effect of Amygdalin on LPS-Induced Acute Lung Injury by Inhibiting NF-κB and NLRP3 Signaling Pathways
- (2017) Ao Zhang et al. INFLAMMATION
- Chinese medicine for diabetic kidney disease in China
- (2017) Yumin Wen et al. NEPHROLOGY
- Oxidative Stress in Diabetic Nephropathy with Early Chronic Kidney Disease
- (2016) Alejandra Guillermina Miranda-Díaz et al. Journal of Diabetes Research
- Abroma augusta L. (Malvaceae) leaf extract attenuates diabetes induced nephropathy and cardiomyopathy via inhibition of oxidative stress and inflammatory response
- (2015) Ritu Khanra et al. Journal of Translational Medicine
- TGF-β/BMP proteins as therapeutic targets in renal fibrosis. Where have we arrived after 25years of trials and tribulations?
- (2015) José M. Muñoz-Félix et al. PHARMACOLOGY & THERAPEUTICS
- Safety of studies analysing clinical benefit of amygdalin
- (2014) Shailendra Kapoor IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Matrix metalloproteinase-9 deficiency attenuates diabetic nephropathy by modulation of podocyte functions and dedifferentiation
- (2014) Szu-Yuan Li et al. KIDNEY INTERNATIONAL
- Amygdalin inhibits renal fibrosis in chronic kidney disease
- (2013) JUNQI GUO et al. Molecular Medicine Reports
- A systems approach identifies HIPK2 as a key regulator of kidney fibrosis
- (2012) Yuanmeng Jin et al. NATURE MEDICINE
- Catalytic degradation of amygdalin by extracellular enzymes from Aspergillus niger
- (2011) Jun Chang et al. PROCESS BIOCHEMISTRY
- Oxidative Stress in Diabetic Nephropathy
- (2010) N. Kashihara et al. CURRENT MEDICINAL CHEMISTRY
- Pathologic Classification of Diabetic Nephropathy
- (2010) T. W. C. Tervaert et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Ultrastructural changes in the glomerular filtration barrier and occurrence of proteinuria in Chinese patients with type 2 diabetic nephropathy
- (2009) Wei-wei Zhu et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureas
- (2008) Małgorzata Wegner et al. CYTOKINE
- The pathogenesis of diabetic nephropathy
- (2008) Suma Dronavalli et al. Nature clinical practice. Endocrinology & metabolism
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now